New study reveals physical activity in midlife and later life can reduce dementia risk by up to 45%, offering significant ...

Share on PinterestNovo Nordisk has announced the cessation of the Evoke trials, looking at whether GLP-1 drugs could help ...

Alzheimer’s disease affects many people worldwide, and while it can be diagnosed, many receive the diagnosis too late. Due to ...

Alzheimer’s disease steals memory, independence and, too often, life itself. Drugs can ease symptoms, but none halt the march ...

New research published in the journal Nature suggests that modest doses of lithium orotate may prevent or even reverse ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as ...

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...

But perhaps the larger story associated with the unsurprising result is the market reaction, as Novo's shares fell by nearly 9% at the U.S. market open Monday.

As more than 7 million Americans live with Alzheimer's, a North Texas family is urging caregivers to seek help early after ...

Q: I'm feeling a little fuzzy-brained and am debating whether to get tested for Alzheimer's. Do you think it's a good idea? -- Cassie R., Knoxville, Tennessee ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...